FY26 Lab Consolidation for Coagulation CPRR Effort
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Jun 1, 2026 |
| Due Date: | Jun 9, 2026 |
| Solicitation No: | HT941026Q2004 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
- Updated Published Date: Jun 01, 2026 07:15 am PDT
- Original Published Date: May 18, 2026 11:48 pm PDT
- Updated Date Offers Due: Jun 09, 2026 01:00 pm PDT
- Original Date Offers Due: Jun 02, 2026 01:00 pm PDT
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Jun 24, 2026
- Original Inactive Date: Jun 17, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
USA
UPDATE: The purpose of this amendment (0002) is to revise the Combined Synopsis Solicitation:
a. Post CSS Coagulation Attachment 3 Quote Sheet Amendment 0002 for feedback; and
b. Feedback due 1300 PST on Wednesday, 3 June 2026 (ensure feedback sent to both POCs).
Acknowledgement of this amendment and any resultant amended quotation shall be submitted utilizing the CSS Coagulation Attachment 3 Quote Sheet. All other paragraphs, provisions, and conditions of this CSS remain unchanged.
UPDATE: The purpose of this amendment is to update the Combined Synopsis and Solicitation (CSS) Questions due date and the Quotations due date. Please see CSS Cover Letter and CSS HT941026Q2004 0001.
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Quotes are being requested, and a separate written solicitation will not be issued. Solicitation Number HT941026Q2004 is issued as a Request for Quotation (RFQ). This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01 effective 03/13/2026 and Defense Federal Acquisition Regulation Supplement (DFARS) change 11/10/2025. The North American Industry Classification System (NAICS) Code for this acquisition is 334516 – Analytical Laboratory Instrument Manufacturing. The size standard is 1000 employees. The Product and Service Code (PSC) for this requirement is 6550 – In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. This acquisition is not set-aside for small business concerns. This is an unrestricted procurement, inviting full and open competition. It is the responsibility of the contractor to be familiar with the applicable clauses and provisions.
The requirement is for a cost per reportable result (CPRR) contract for coagulation analyzers to support military treatment facilities (MTFs) and their workloads (see CSS for list of MTFs).
- 2739T ROOSEVELT DRIVE OFFICE 143, BUILDING H-201T
- CAMP PENDLETON , CA 92055
- USA
- Bobbie Dobberstein
- bobbie.s.dobberstein.ctr@health.mil
- Phone Number 4789194484
- CHA-ON Gordon
- cha-on.p.gordon2.civ@health.mil
- Phone Number 7262030109
- Jun 01, 2026 07:15 am PDTCombined Synopsis/Solicitation (Updated)
- May 20, 2026 06:24 am PDT Combined Synopsis/Solicitation (Updated)
- May 18, 2026 11:48 pm PDT Combined Synopsis/Solicitation (Original)
- Feb 27, 2026 09:13 pm PST Presolicitation (Updated)
Related Document
See Also
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 10/02/2026